Guidance document : cancellation of a drug identification number (DIN) and notification of discontinuation of sales.: H13-9/10-2018E-PDF
"A Drug Identification Number (DIN) serves as an identifier of a drug and its associated characteristics. The assignment of a DIN indicates that a drug has undergone a successful Health Canada review process and is currently authorized for sale in Canada. The purpose of this guidance document is to provide assistance in interpreting sections C.01.014.6 and C.01.014.7 of the Regulations for the cancellation of a DIN and the notification to Health Canada of the discontinuation of the sale of a drug"--P. 7.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.854395&sl=0
| Department/Agency | Canada. Health Canada. |
|---|---|
| Title | Guidance document : cancellation of a drug identification number (DIN) and notification of discontinuation of sales. |
| Variant title | Cancellation of a drug identification number (DIN) and notification of discontinuation of sales Cancellation of a DIN & notification of discontinuation of sales |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Ligne directrice : annulation d’une identification numérique d’une drogue (DIN) et avis de cessation de la vente d’une drogue. Cover title. "Date adopted: 2017/03/14. Revision date: 2018/06/13. Effective date: 2018/06/13." "Publication date: June 2018." Issued also in HTML format. Includes bibliographical references. |
| Publishing information | Ottawa : Health Canada, 2018. |
| Description | 18 p. |
| ISBN | 9780660260105 |
| Catalogue number |
|
| Departmental catalogue number | 170513 |
| Subject terms | Drugs Product elimination Handbooks |